Publicaciones en las que colabora con Cristina Rodríguez González (9)

2024

  1. Preclinical validation of human recombinant glutamate-oxaloacetate transaminase for the treatment of acute ischemic stroke

    iScience, Vol. 27, Núm. 11

2021

  1. Mitochondrial–nuclear p53 trafficking controls neuronal susceptibility in stroke

    IUBMB Life, Vol. 73, Núm. 3, pp. 582-591

  2. Preconditioning‐activated akt controls neuronal tolerance to ischemia through the mdm2–p53 pathway

    International Journal of Molecular Sciences, Vol. 22, Núm. 14

  3. Refocusing the Brain: New Approaches in Neuroprotection Against Ischemic Injury

    Neurochemical Research, Vol. 46, Núm. 1, pp. 51-63

2020

  1. Nuclear WRAP53 promotes neuronal survival and functional recovery after stroke

    Science advances, Vol. 6, Núm. 41

2019

  1. A novel human Cdh1 mutation impairs anaphase promoting complex/cyclosome activity resulting in microcephaly, psychomotor retardation, and epilepsy

    Journal of Neurochemistry, Vol. 151, Núm. 1, pp. 103-115

  2. The Neuronal Ischemic Tolerance Is Conditioned by the Tp53 Arg72Pro Polymorphism

    Translational Stroke Research, Vol. 10, Núm. 2, pp. 204-215

2018

  1. Single-nucleotide polymorphism 309T>G in the MDM2 promoter determines functional outcome after stroke

    Stroke, Vol. 49, Núm. 10, pp. 2437-2444

2017

  1. Neovascularization and functional recovery after intracerebral hemorrhage is conditioned by the Tp53 Arg72Pro single-nucleotide polymorphism

    Cell Death and Differentiation, Vol. 24, Núm. 1, pp. 144-154